No IGF-1 or glucose disruption: Unlike HGH, AOD-9604 does not significantly increase IGF-1 or negatively affect insulin sensitivity, making it a safer candidate for metabolic regulation Benefits of AOD-9604 When dosed consistently, AOD-9604 provides targeted fat-burning and metabolic support without the systemic hormonal risks seen with full-length HGH
AOD9604 has been characterised across pre-clinical, safety pharmacology, and early-phase clinical research since the late 1990s, with peer-reviewed publications spanning lipid metabolism, adipose biology, joint repair, and bioavailability
Any clinical use of AOD 9604 today is off-label and falls under the supervision of a licensed provider using a compounded preparation
Moreover, those lacking in Vitamin B12 may experience discomfort in the mouth and on the tongue, highlighting the far-reaching effects on overall health